Working Groups

Active?
Facet Toggle

A New Grand Bargain to Improve the Antimicrobial Market for Human Health
Amanda Glassman
et al.
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
Innovative Finance for Resettlement Working Group
Cindy Huang
et al.
May 09, 2017
The Innovative Finance for Resettlement Working Group aims to create more and better opportunities for displaced people to be safely resettled in third countries. The Working Group is developing proposals and setting out practical actions for donors and governments to use innovative financing and re...
Forced Displacement and Development Study Group
Cindy Huang
et al.
September 15, 2016
CGD and IRC are convening a joint study group to explore what a sound partnership framework between host governments and development and humanitarian actors might look like in protracted displacement scenarios. This effort is guided by a vision of displaced people having meaningful opportunities tha...
Payouts for Perils: Insurance Contracts for Better Emergency and Humanitarian Aid
Owen Barder
et al.
July 08, 2016
Humanitarian and emergency assistance is overstretched and underfunded. Many people living in countries with weak or cash-strapped government services live with the daily risk of disaster. This working group is examining how vulnerable countries and frontline humanitarian agencies can make use ...
Improving Migration Data (May 2008–May 2009)
Devesh Kapur
et al.
September 11, 2014
Drug Resistance Working Group (November 2007 – June 2010)
Amanda Glassman
and
Prashant Yadav
September 10, 2014
Value for Money: An Agenda for Global Health Funding Agencies
Amanda Glassman
et al.
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM)  agenda aims to reduce costs, increase imp...